Ablative Solutions Stock

ablativesolutions.comHealthcareFounded: 2011Funding to Date: $127.35MM

Ablative Solutions is a clinical-stage medical device start-up that is pioneering the novel approach of Transcatheter Perivascular Alcohol Denervation for the treatment of hypertension.

Register for Details

For more details on financing and valuation for Ablative Solutions, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Ablative Solutions.

Register Today

Team

Management Team

Kathryn Rumrill
President, Chief Executive Officer & Board Member
Phillip Torrence JD
Board Member & Secretary
Tim Fischell MD
Chief Medical Officer
Nicole Haratani
Vice President of Global Clinical, Regulatory Affairs and Quality

Board Members

Kathryn Rumrill
Ablative Solutions
Paul Buckman
David Fischell Ph.D
Dale Grogan
Michigan Accelerator Fund 1
Geoff Pardo
Gilde Healthcare Partners
Phillip Torrence JD

Other companies like Ablative Solutions in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
 
 
Sector
Last Round Est. Valuation
$317.32MM
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$1.59B
Sector
Last Round Est. Valuation
$4.26B
Sector
 
 

News

Ablative Solutions, Inc., a company pioneering new approaches to the treatment of hypertension, today announced that Kate Rumrill has been appointed a
Ablative Solutions, a company advancing innovative solutions for the treatment of hypertension, held the first close of its $77m Series D funding